FORMERLY
VITAE INDUSTRIES
VITAE INDUSTRIES
Empowering
Pharmacies
BetteRx empowers compound pharmacists to deliver a simply better, safer, more compliant prescription to enhance patient care and improve pharmacy workflow.
FORMERLY
VITAE INDUSTRIES
Empowering
Pharmacies
BetteRx empowers compound pharmacists to deliver a simply better, safer, more compliant prescription to enhance patient care and improve pharmacy workflow.
Our Core Mission
Our Core Mission
Revolutionizing Personalized Medicine Through Innovative Technology
Revolutionizing Personalized Medicine Through Innovative Technology
Commitment to Quality
We're leading the charge in transforming personalized medicine, with our system already in over 28 pharmacies nationwide. Our solution meets the rigorous standards of the Drug Quality and Security Act, enacted after the NECC meningitis outbreak, underscoring our commitment to safety and quality.
Innovation and Safety
Our mission is to make personalized medication safer, more effective, and as accessible as generic drugs. We can do this by empowering 503A compounding pharmacists with advanced technology that aligns perfectly with FDA regulations, ensuring the highest safety standards.
Commitment to Quality
We're leading the charge in transforming personalized medicine, with our system already in over 28 pharmacies nationwide. Our solution meets the rigorous standards of the Drug Quality and Security Act, enacted after the NECC meningitis outbreak, underscoring our commitment to safety and quality.
Innovation and Safety
Our mission is to make personalized medication safer, more effective, and as accessible as generic drugs. We can do this by empowering 503A compounding pharmacists with advanced technology that aligns perfectly with FDA regulations, ensuring the highest safety standards.
BetteRx acquired Vitae Industries' Technology
System Demonstration
System Demonstration
Effortless Process,
Continuous Supply
01.
PREPARE THE COMPOUND
Mix the drug (API) with the dosage form-specific inactive ingredients to our vetted formulas.
01.
PREPARE THE COMPOUND
Mix the drug (API) with the dosage form-specific inactive ingredients to our vetted formulas.
02.
FILL AND INSERT CARTRIDGE
Fill our cartridges with the compound and clip it into the AutoCompounder.
02.
FILL AND INSERT CARTRIDGE
Fill our cartridges with the compound and clip it into the AutoCompounder.
03.
MAKE DOSAGES
Enter the drug, stength(s), and quantity. Clock start and walk away!
03.
MAKE DOSAGES
Enter the drug, stength(s), and quantity. Clock start and walk away!
Effortless Process,
Continuous Supply
01.
PREPARE THE COMPOUND
Mix the drug (API) with the dosage form-specific inactive ingredients to our vetted formulas.
02.
FILL AND INSERT CARTRIDGE
Fill our cartridges with the compound and clip it into the AutoCompounder.
03.
MAKE DOSAGES
Enter the drug, stength(s), and quantity. Clock start and walk away!
Achievements at a glance
Pioneering the Future of Compounded Medications
Pioneering the Future
of Compounded Medications
BetteRx has revolutionized personalized compounding with cutting-edge technology that streamlines and automates the dispensing process. Our innovative system ensures precision, efficiency, and scalability, enabling pharmacists to deliver customized medications with unprecedented accuracy. With a commitment to quality and patient safety, we are setting a new standard for the future of pharmacy.
BetteRx has revolutionized personalized compounding with cutting-edge technology that streamlines and automates the dispensing process. Our innovative system ensures precision, efficiency, and scalability, enabling pharmacists to deliver customized medications with unprecedented accuracy. With a commitment to quality and patient safety, we are setting a new standard for the future of pharmacy.
Achievements at a glance
Pioneering the Future of Compounded Medications
BetteRx has revolutionized personalized compounding with cutting-edge technology that streamlines and automates the dispensing process. Our innovative system ensures precision, efficiency, and scalability, enabling pharmacists to deliver customized medications with unprecedented accuracy. With a commitment to quality and patient safety, we are setting a new standard for the future of pharmacy.
300+
Compound
Formulary API's
28
pharmacy
installations
500K+
Autocompounder
dispensed Doses
300+
Compound
Formulary API's
28
pharmacy
installations
500K+
Autocompounder
dispensed Doses
Our Team
We have a strong team committed to innovating the pharmaceutical industry by making personalized medication as scalable and available as generic drugs are today.
We have a strong team committed to innovating the pharmaceutical industry by making personalized medication as scalable and available as generic drugs are today.
Anthony Marsella
CEO, Co-Founder
Anthony Marsella
Founder & CEO
Daniel DeCiccio
Co-Founder & CTO
Stuart Jamieson
CFO
James Hussey, Rph
Board Advisor
Thomas DePetrillo
Partner & Board Chairman
Richard Nicholson, Esq.
General Counsel
John Harwood, Esq.
Board Advisor
Anthony Marsella
Founder & CEO
Daniel DeCiccio
Co-Founder & CTO
Stuart Jamieson
CFO
James Hussey, Rph
Board Advisor
Thomas DePetrillo
Partner & Board Chairman
Richard Nicholson, Esq.
General Counsel
John Harwood, Esq.
Board Advisor
Anthony Marsella
Founder & CEO
Daniel DeCiccio
Co-Founder & CTO
Stuart Jamieson
CFO
James Hussey, Rph
Board Advisor
Thomas DePetrillo
Partner & Board Chairman
Richard Nicholson, Esq.
General Counsel
John Harwood, Esq.
Board Advisor
Anthony Marsella
Founder & CEO
Daniel DeCiccio
Co-Founder & CTO
Stuart Jamieson
CFO
James Hussey, Rph
Board Advisor
Thomas DePetrillo
Partner & Board Chairman
Richard Nicholson, Esq.
General Counsel
John Harwood, Esq.
Board Advisor
Anthony Marsella
Founder & CEO
Daniel DeCiccio
Co-Founder & CTO
Stuart Jamieson
CFO
James Hussey, Rph
Board Advisor
Thomas DePetrillo
Partner & Board Chairman
Richard Nicholson, Esq.
General Counsel
John Harwood, Esq.
Board Advisor
Anthony Marsella
Founder & CEO
Daniel DeCiccio
Co-Founder & CTO
Stuart Jamieson
CFO
James Hussey, Rph
Board Advisor
Thomas DePetrillo
Partner & Board Chairman
Richard Nicholson, Esq.
General Counsel
John Harwood, Esq.
Board Advisor
Anthony Marsella
Founder & CEO
Daniel DeCiccio
Co-Founder & CTO
Stuart Jamieson
CFO
James Hussey, Rph
Board Advisor
Thomas DePetrillo
Partner & Board Chairman
Richard Nicholson, Esq.
General Counsel
John Harwood, Esq.
Board Advisor
Anthony Marsella
Founder & CEO
Daniel DeCiccio
Co-Founder & CTO
Stuart Jamieson
CFO
James Hussey, Rph
Board Advisor
Thomas DePetrillo
Partner & Board Chairman
Richard Nicholson, Esq.
General Counsel
John Harwood, Esq.
Board Advisor
Our Team
We have a strong team committed to innovating the pharmaceutical industry by making personalized medication as scalable and available as generic drugs are today.
Anthony Marsella
CEO, Co-Founder
Anthony Marsella
Founder & CEO
Daniel DeCiccio
Co-Founder & CTO
Stuart Jamieson
CFO
James Hussey, Rph
Board Advisor
Thomas DePetrillo
Partner & Board Chairman
Richard Nicholson, Esq.
General Counsel
John Harwood, Esq.
Board Advisor
Anthony Marsella
Founder & CEO
Daniel DeCiccio
Co-Founder & CTO
Stuart Jamieson
CFO
James Hussey, Rph
Board Advisor
Thomas DePetrillo
Partner & Board Chairman
Richard Nicholson, Esq.
General Counsel
John Harwood, Esq.
Board Advisor
Anthony Marsella
Founder & CEO
Daniel DeCiccio
Co-Founder & CTO
Stuart Jamieson
CFO
James Hussey, Rph
Board Advisor
Thomas DePetrillo
Partner & Board Chairman
Richard Nicholson, Esq.
General Counsel
John Harwood, Esq.
Board Advisor
Anthony Marsella
Founder & CEO
Daniel DeCiccio
Co-Founder & CTO
Stuart Jamieson
CFO
James Hussey, Rph
Board Advisor
Thomas DePetrillo
Partner & Board Chairman
Richard Nicholson, Esq.
General Counsel
John Harwood, Esq.
Board Advisor
BetteRx Is Proud To Be The First Member Of PDG Who's Industry Focus Is Compounding
BetteRx Is Proud To Be The First Member Of PDG Who's Industry Focus Is Compounding
BetteRx Is Proud To Be The First Member Of PDG Who's Industry Focus Is Compounding
Partnership for DSCSA Governance is a collaborative forum and FDA public-private partnership dedicated to developing, advancing, and sustaining an effective and efficient model for interoperable tracing and verification of prescription pharmaceuticals in the U.S.
Partnership for DSCSA Governance is a collaborative forum and FDA public-private partnership dedicated to developing, advancing, and sustaining an effective and efficient model for interoperable tracing and verification of prescription pharmaceuticals in the U.S.
Partnership for DSCSA Governance is a collaborative forum and FDA public-private partnership dedicated to developing, advancing, and sustaining an effective and efficient model for interoperable tracing and verification of prescription pharmaceuticals in the U.S.
Read More about BetteRx
Read More about BetteRx
Vitae Industries in the New York Times
A Fraught New Frontier in Telehealth: Ketamine
Vitae Industries in the New York Times
A Fraught New Frontier in Telehealth: Ketamine
Vitae Industries in Bloomberg
This Toaster-Size 3D Printer Can Make Drugs
Vitae Industries in Bloomberg
This Toaster-Size 3D Printer Can Make Drugs
Vitae Industries in the New York Post
3D printing firm focuses on ventilator parts in coronavirus fight
Vitae Industries in the New York Post
3D printing firm focuses on ventilator parts in coronavirus fight
Read More about BetteRx
Vitae Industries in the New York Times
A Fraught New Frontier in Telehealth: Ketamine
Vitae Industries in Bloomberg
This Toaster-Size 3D Printer Can Make Drugs
Vitae Industries in the New York Post